Jean Louis Pujol

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

Thierry Le Chevalier, D. Brisgand, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1994 · 823 citations

Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications

Fabrice André, Dominique Grunenwald, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2000 · 486 citations

Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01

Jean Louis Pujol, Jean Luc Breton, Radj Gervais et al. · Journal of Clinical Oncology · 2007 · 142 citations · Full text

Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy

Fabrice André, Dominique Grunenwald, Jean Louis Pujol et al. · Cancer · 2001 · 126 citations

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

R. Gervais, A Ducoloné, Jean-Luc Breton et al. · Annals of Oncology · 2004 · 117 citations

Weekly Schedule, Phase Ii, Advanced Lung Disease +11